The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Current patterns and costs associated with oral and injectable therapy for metastatic breast cancer in U.S. women: A SEER-Medicare analysis.
Hope S. Rugo
Consultant or Advisory Role - Eisai
Karen Clements
Consultant or Advisory Role - Eisai
Lisa McGarry
Consultant or Advisory Role - Eisai
Claudio Faria
Employment or Leadership Position - Eisai
April H. Teitelbaum
Consultant or Advisory Role - Eisai